FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912018514> ?p ?o ?g. }

• W2912018514 endingPage "1746" @default.
• W2912018514 startingPage "1736" @default.
• W2912018514 abstract "Triplet combinations containing a proteasome inhibitor are a standard of care in newly diagnosed multiple myeloma (NDMM). We examined the long-term efficacy and safety of the all-oral combination of weekly ixazomib plus lenalidomide-dexamethasone (IRd), followed by single-agent ixazomib maintenance in NDMM patients. Of 65 enrolled patients, 53 received ixazomib 4 mg (days 1, 8, and 15) plus lenalidomide 25 mg (days 1–21) and dexamethasone 40 mg (days 1, 8, 15, and 22) for up to twelve 28-day induction cycles. Twenty-three patients discontinued induction for stem cell transplantation (SCT). In the remaining 42 patients, overall response rate was 80%, including 63% ≥very good partial response (VGPR) and 32% complete responses. At a median follow-up of 56 months, median progression-free survival (PFS) was 35.4 months in the total population. Twenty-five patients received ixazomib maintenance; eight deepened their response (76% ≥VGPR), and median PFS was 37.2 months in this subgroup. Nine of 42 patients who did not proceed to SCT (14% of total population) had an adverse event requiring discontinuation. Ixazomib (median ≥ 96%) and lenalidomide (median 88–94%) relative dose intensities were maintained throughout treatment. Weekly IRd, followed by ixazomib maintenance, was highly active with acceptable toxicity, enabling long-term administration with no evidence of cumulative toxicities." @default.
• W2912018514 created "2019-02-21" @default.
• W2912018514 creator A5011030256 @default.
• W2912018514 creator A5016419792 @default.
• W2912018514 creator A5023276777 @default.
• W2912018514 creator A5026574827 @default.
• W2912018514 creator A5031690184 @default.
• W2912018514 creator A5041742828 @default.
• W2912018514 creator A5043526996 @default.
• W2912018514 creator A5049711954 @default.
• W2912018514 creator A5050961257 @default.
• W2912018514 creator A5052345783 @default.
• W2912018514 creator A5066940168 @default.
• W2912018514 creator A5069676334 @default.
• W2912018514 creator A5077846750 @default.
• W2912018514 creator A5077897003 @default.
• W2912018514 creator A5091287816 @default.
• W2912018514 date "2019-01-29" @default.
• W2912018514 modified "2023-10-15" @default.
• W2912018514 title "Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance" @default.
• W2912018514 cites W1801735820 @default.
• W2912018514 cites W1955748620 @default.
• W2912018514 cites W1969648097 @default.
• W2912018514 cites W1978377409 @default.
• W2912018514 cites W1979068418 @default.
• W2912018514 cites W1993959807 @default.
• W2912018514 cites W2009426416 @default.
• W2912018514 cites W2013370486 @default.
• W2912018514 cites W2018729528 @default.
• W2912018514 cites W2028195916 @default.
• W2912018514 cites W2035992346 @default.
• W2912018514 cites W2037132614 @default.
• W2912018514 cites W2044436186 @default.
• W2912018514 cites W2055338149 @default.
• W2912018514 cites W2065859796 @default.
• W2912018514 cites W2068622908 @default.
• W2912018514 cites W2080030013 @default.
• W2912018514 cites W2095384810 @default.
• W2912018514 cites W2096207943 @default.
• W2912018514 cites W2107384529 @default.
• W2912018514 cites W2108235071 @default.
• W2912018514 cites W2142368474 @default.
• W2912018514 cites W2160188479 @default.
• W2912018514 cites W2343386476 @default.
• W2912018514 cites W2529434198 @default.
• W2912018514 cites W2537692707 @default.
• W2912018514 cites W2567188480 @default.
• W2912018514 cites W2604776612 @default.
• W2912018514 cites W2614011808 @default.
• W2912018514 cites W2734904855 @default.
• W2912018514 cites W2740395975 @default.
• W2912018514 cites W2749669815 @default.
• W2912018514 cites W2766948867 @default.
• W2912018514 cites W2769593282 @default.
• W2912018514 cites W2904778784 @default.
• W2912018514 cites W4211058750 @default.
• W2912018514 cites W4211114373 @default.
• W2912018514 doi "https://doi.org/10.1038/s41375-019-0384-1" @default.
• W2912018514 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6755968" @default.
• W2912018514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30696949" @default.
• W2912018514 hasPublicationYear "2019" @default.
• W2912018514 type Work @default.
• W2912018514 sameAs 2912018514 @default.
• W2912018514 citedByCount "42" @default.
• W2912018514 countsByYear W29120185142019 @default.
• W2912018514 countsByYear W29120185142020 @default.
• W2912018514 countsByYear W29120185142021 @default.
• W2912018514 countsByYear W29120185142022 @default.
• W2912018514 countsByYear W29120185142023 @default.
• W2912018514 crossrefType "journal-article" @default.
• W2912018514 hasAuthorship W2912018514A5011030256 @default.
• W2912018514 hasAuthorship W2912018514A5016419792 @default.
• W2912018514 hasAuthorship W2912018514A5023276777 @default.
• W2912018514 hasAuthorship W2912018514A5026574827 @default.
• W2912018514 hasAuthorship W2912018514A5031690184 @default.
• W2912018514 hasAuthorship W2912018514A5041742828 @default.
• W2912018514 hasAuthorship W2912018514A5043526996 @default.
• W2912018514 hasAuthorship W2912018514A5049711954 @default.
• W2912018514 hasAuthorship W2912018514A5050961257 @default.
• W2912018514 hasAuthorship W2912018514A5052345783 @default.
• W2912018514 hasAuthorship W2912018514A5066940168 @default.
• W2912018514 hasAuthorship W2912018514A5069676334 @default.
• W2912018514 hasAuthorship W2912018514A5077846750 @default.
• W2912018514 hasAuthorship W2912018514A5077897003 @default.
• W2912018514 hasAuthorship W2912018514A5091287816 @default.
• W2912018514 hasBestOaLocation W29120185141 @default.
• W2912018514 hasConcept C126322002 @default.
• W2912018514 hasConcept C141071460 @default.
• W2912018514 hasConcept C197934379 @default.
• W2912018514 hasConcept C2776063141 @default.
• W2912018514 hasConcept C2776364478 @default.
• W2912018514 hasConcept C2776694085 @default.
• W2912018514 hasConcept C2778283404 @default.
• W2912018514 hasConcept C2778367456 @default.
• W2912018514 hasConcept C2778715236 @default.
• W2912018514 hasConcept C2780108899 @default.
• W2912018514 hasConcept C2780401358 @default.
• W2912018514 hasConcept C2781098529 @default.

• next